Pharming Group N.V.

PHARM.AS · AMS
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents€132,370€92,091€60,093€54,944
Short-Term Investments€33,798€33,917€47,180€112,949
Receivables€43,606€53,327€47,487€50,172
Inventory€67,136€63,715€59,346€55,724
Other Curr. Assets€690€2,726€0€0
Total Curr. Assets€277,600€245,776€214,106€278,440
Property Plant & Equip (Net)€24,992€24,566€24,227€24,134
Goodwill€0€0€0€0
Intangibles€0€53,327€47,487€61,039
Long-Term Investments€6,673€6,698€5,922€4,233
Tax Assets€27,485€31,200€18,390€30,544
Other NC Assets€2,109€2,118€1,673€1,595
Total NC Assets€196,185€200,483€189,075€121,545
Other Assets€0€0€0€0
Total Assets€473,785€446,259€403,181€399,985
Liabilities
Payables€78,221€78,382€68,748€10,103
Short-Term Debt€5,210€5,105€4,555€4,245
Tax Payable€0€0€0€3,284
Deferred Revenue€0€0€0€0
Other Curr. Liab.-€1€0€0€0
Total Curr. Liab.€87,914€87,942€77,536€73,802
LT Debt€93,138€91,268€83,849€78,154
Deferred Rev, NC€0€0€0€0
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.-€1€0€0€0
Total NC Liab.€121,227€118,766€110,355€105,122
Other Liabilities€0€0€0€0
Cap. Leases€32,574€31,953€30,739€29,914
Total Liabilities€209,141€206,708€187,891€178,924
Equity
Pref Stock€0€0€0€0
Common Stock€7,953€7,821€7,806€7,769
Retained Earnings-€276,878-€286,031-€292,801-€275,489
AOCI€25,852€25,908€8,692-€209
Other Equity€0€0€0€0
Total Equity€264,644€239,551€213,998€221,061
Supplemental Information
Minority Interest€0€0€1,292€0
Total Liab. & Tot. Equity€473,785€446,259€403,181€399,985
Net Debt-€34,022€4,282€28,311€27,455
Pharming Group N.V. (PHARM.AS) Financial Statements & Key Stats | AlphaPilot